Prognostic significance of regression and mitotic rate in head and neck cutaneous melanoma

Abstract Importance While regression is a commonly reported microscopic feature of melanoma, its prognostic significance is unclear. Objective To examine the impact of regression on sentinel node status and the likelihood of recurrence in primary cutaneous melanoma of the head and neck. Design Retro...

Full description

Bibliographic Details
Main Authors: Elizabeth Kim, Isaac Obermeyer, Nathan Rubin, Samir S. Khariwala
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:Laryngoscope Investigative Otolaryngology
Online Access:https://doi.org/10.1002/lio2.509
id doaj-63db74ef292d4b6bb0ade83947b6e5cd
record_format Article
spelling doaj-63db74ef292d4b6bb0ade83947b6e5cd2021-02-15T12:54:20ZengWileyLaryngoscope Investigative Otolaryngology2378-80382021-02-016110911510.1002/lio2.509Prognostic significance of regression and mitotic rate in head and neck cutaneous melanomaElizabeth Kim0Isaac Obermeyer1Nathan Rubin2Samir S. Khariwala3Department of Otolaryngology‐Head and Neck Surgery University of Minnesota Minneapolis Minnesota USADepartment of Otolaryngology‐Head and Neck Surgery University of Minnesota Minneapolis Minnesota USABiostatistics Core, Masonic Cancer Center University of Minnesota Minneapolis Minnesota USADepartment of Otolaryngology‐Head and Neck Surgery University of Minnesota Minneapolis Minnesota USAAbstract Importance While regression is a commonly reported microscopic feature of melanoma, its prognostic significance is unclear. Objective To examine the impact of regression on sentinel node status and the likelihood of recurrence in primary cutaneous melanoma of the head and neck. Design Retrospective analysis of 191 adults who underwent surgical management for primary cutaneous melanoma of the head and neck between May 2002 and March 2019. Setting Tertiary academic center. Participants Patients appropriate for the study were identified by the Academic Health Center Information Exchange using a list of current procedural terminology codes. One hundred and ninety‐one cases of invasive melanoma of the head and neck were included from 830 patients identified. Clinical features assessed for each patient included age, sex, location of primary lesion, date of diagnosis, and current disease status (alive with or without disease). Histologic features assessed were histological melanoma subtype (nodular vs non‐nodular), Breslow thickness, Clark level, presence/absence of ulceration, mitotic rate per square millimeter, and regression. If applicable, sentinel lymph node biopsy (SLNB) status, date of recurrence, interval treatments, and date of death related to melanoma were recorded. Exclusion criteria included melanoma outside the anatomic parameters of head and neck, ocular or choroidal melanoma, mucosal melanoma, metastatic melanoma to the head or neck with no known primary tumor, melanoma of the head or neck with no surgical intervention, and non‐melanoma skin cancers of the head and neck. Intervention/Exposure Surgery for cutaneous melanoma of the head and neck. Main Outcome(s) and Measure(s) The association between presence of regression and Breslow thickness, sentinel node status, and recurrence. Results Of the 191 patients identified, 30.9% were female and 69.1% were male with a mean age at diagnosis of 62.6 (range 20‐97) years. Mean Breslow thickness was 1.2 mm in those with regression and 2.0 mm in those without regression. In patients with regression, 17.6% had a positive sentinel node, and 13.0% experienced a recurrence. In patients without regression, 26.5% had a positive sentinel node, and 31.4% experienced a recurrence. When adjusted for other factors above, regression was not associated with positive sentinel node (odds ratio [OR] = 0.59, 95% confidence interval [CI] = 0.13‐2.00) or recurrence (OR = 0.33, CI = 0.07‐1.01). Mitotic rate >2 was associated with recurrence (OR = 2.71, CI = 1.11‐6.75, P = .03). Conclusions and Relevance Patients with presence of regression had thinner melanomas and trended toward decreased rates of sentinel node positivity and recurrence, suggesting regression may not be a negative prognostic indicator in patients with cutaneous melanoma of the head and neck.https://doi.org/10.1002/lio2.509
collection DOAJ
language English
format Article
sources DOAJ
author Elizabeth Kim
Isaac Obermeyer
Nathan Rubin
Samir S. Khariwala
spellingShingle Elizabeth Kim
Isaac Obermeyer
Nathan Rubin
Samir S. Khariwala
Prognostic significance of regression and mitotic rate in head and neck cutaneous melanoma
Laryngoscope Investigative Otolaryngology
author_facet Elizabeth Kim
Isaac Obermeyer
Nathan Rubin
Samir S. Khariwala
author_sort Elizabeth Kim
title Prognostic significance of regression and mitotic rate in head and neck cutaneous melanoma
title_short Prognostic significance of regression and mitotic rate in head and neck cutaneous melanoma
title_full Prognostic significance of regression and mitotic rate in head and neck cutaneous melanoma
title_fullStr Prognostic significance of regression and mitotic rate in head and neck cutaneous melanoma
title_full_unstemmed Prognostic significance of regression and mitotic rate in head and neck cutaneous melanoma
title_sort prognostic significance of regression and mitotic rate in head and neck cutaneous melanoma
publisher Wiley
series Laryngoscope Investigative Otolaryngology
issn 2378-8038
publishDate 2021-02-01
description Abstract Importance While regression is a commonly reported microscopic feature of melanoma, its prognostic significance is unclear. Objective To examine the impact of regression on sentinel node status and the likelihood of recurrence in primary cutaneous melanoma of the head and neck. Design Retrospective analysis of 191 adults who underwent surgical management for primary cutaneous melanoma of the head and neck between May 2002 and March 2019. Setting Tertiary academic center. Participants Patients appropriate for the study were identified by the Academic Health Center Information Exchange using a list of current procedural terminology codes. One hundred and ninety‐one cases of invasive melanoma of the head and neck were included from 830 patients identified. Clinical features assessed for each patient included age, sex, location of primary lesion, date of diagnosis, and current disease status (alive with or without disease). Histologic features assessed were histological melanoma subtype (nodular vs non‐nodular), Breslow thickness, Clark level, presence/absence of ulceration, mitotic rate per square millimeter, and regression. If applicable, sentinel lymph node biopsy (SLNB) status, date of recurrence, interval treatments, and date of death related to melanoma were recorded. Exclusion criteria included melanoma outside the anatomic parameters of head and neck, ocular or choroidal melanoma, mucosal melanoma, metastatic melanoma to the head or neck with no known primary tumor, melanoma of the head or neck with no surgical intervention, and non‐melanoma skin cancers of the head and neck. Intervention/Exposure Surgery for cutaneous melanoma of the head and neck. Main Outcome(s) and Measure(s) The association between presence of regression and Breslow thickness, sentinel node status, and recurrence. Results Of the 191 patients identified, 30.9% were female and 69.1% were male with a mean age at diagnosis of 62.6 (range 20‐97) years. Mean Breslow thickness was 1.2 mm in those with regression and 2.0 mm in those without regression. In patients with regression, 17.6% had a positive sentinel node, and 13.0% experienced a recurrence. In patients without regression, 26.5% had a positive sentinel node, and 31.4% experienced a recurrence. When adjusted for other factors above, regression was not associated with positive sentinel node (odds ratio [OR] = 0.59, 95% confidence interval [CI] = 0.13‐2.00) or recurrence (OR = 0.33, CI = 0.07‐1.01). Mitotic rate >2 was associated with recurrence (OR = 2.71, CI = 1.11‐6.75, P = .03). Conclusions and Relevance Patients with presence of regression had thinner melanomas and trended toward decreased rates of sentinel node positivity and recurrence, suggesting regression may not be a negative prognostic indicator in patients with cutaneous melanoma of the head and neck.
url https://doi.org/10.1002/lio2.509
work_keys_str_mv AT elizabethkim prognosticsignificanceofregressionandmitoticrateinheadandneckcutaneousmelanoma
AT isaacobermeyer prognosticsignificanceofregressionandmitoticrateinheadandneckcutaneousmelanoma
AT nathanrubin prognosticsignificanceofregressionandmitoticrateinheadandneckcutaneousmelanoma
AT samirskhariwala prognosticsignificanceofregressionandmitoticrateinheadandneckcutaneousmelanoma
_version_ 1724268958049107968